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IL-15 is recognized as a promising candidate for tumor
immunotherapy and has been described as both a pro-
moter of cancer and a promoter of anti-cancer immu-
nity. IL-15 was discovered in cells transformed by
HTLV-1, the etiologic agent of adult T cell leukemia /
lymphoma (ATL) and the human retrovirus that carries
the Tax oncogene. We have developed the TAX-LUC
mouse model of ATL in which Tax expression drives
both malignant transformation and luciferase expression,
enabling non-invasive imaging of tumorigenesis in real
time. To identify the role of IL-15 in spontaneous devel-
opment of lymphoma in vivo, an IL-15-/- TAX-LUC
strain was developed and examined. The absence of
IL-15 resulted in aggressive tumor growth and acceler-
ated mortality and demonstrated that IL-15 was not
required for Tax-mediated lymphoma but was essential
for anti-tumor immunity. Further analysis revealed a
unique transcriptional profile in tumor cells that arise in
the absence of IL-15 that included a significant increase
in the expression of IL-1a and IL-1a-regulated cytokines.
Moreover, anti-IL-1a antibodies and an IL-1 receptor
antagonist (Anakinra) were used to interrogate the
potential of IL-1a targeted therapies in this model.
Taken together, these findings identify IL-15 and IL-1a
as therapeutic targets in lymphoma.
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